NASDAQ: GEVO

Gevo, Inc.

CIK 0001392380 · SIC 2860 · Industrial Organic Chemicals

Small Revenue $161M Assets $491M as of Aug 23, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (PURR 10-K) is open in full — no account needed.

8-K Filed Aug 26, 2026 · Period ending Aug 20, 2026

Summary not yet generated.

8-K Filed Aug 6, 2026 · Period ending Aug 6, 2026

Summary not yet generated.

Partner

Trade GEVO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed Aug 6, 2026 · Period ending Jun 30, 2026 Standing risk

GEVO: revenue $46.5M, net income -$176.9M. Gevo swings to operating loss on ATJ-180 impairment, deposit write-down

5 material changes detected. Sign up free to read the summary.

8-K Filed Jul 16, 2026 · Period ending Jul 13, 2026

Gevo appoints former ADM Chief Science Officer Todd Werpy to Board of Directors

4 material changes detected. Sign up free to read the summary.

8-K Filed Jul 15, 2026 · Period ending Jul 15, 2026

Gevo targets more than doubled 2026 Adjusted EBITDA on carbon pathway expansion

5 material changes detected. Sign up free to read the summary.

8-K Filed May 26, 2026 · Period ending May 20, 2026

Summary not yet generated.

10-Q Filed May 7, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed May 7, 2026 · Period ending May 7, 2026

Summary not yet generated.

10-K Filed Mar 5, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 10, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 11, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Mar 27, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 6, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(Unaudited, in thousands, except share and per share amounts)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Total revenues 46,501 43,413 89,449 72,522
Cost of production 19,918 17,265 40,150 38,711
Depreciation and amortization 6,784 7,213 13,644 12,835
Gross profit 19,799 18,935 35,655 20,976
Operating expenses:
Research and development expense 440 934 1,939 1,986
General and administrative expense 12,882 10,783 29,097 21,867
Project development costs 2,403 831 5,443 5,833
Acquisition related costs 4,438
Facility idling costs 591 1,195
Impairment of long-lived assets 135,788 135,788
Allowance for credit losses on refundable deposits 39,782 39,782
Loss on disposal of assets, net 210 210
Total operating expenses 191,505 13,139 212,259 35,319
(Loss) income from operations (171,706) 5,796 (176,604) (14,343)
Other (expense) income
Interest expense (5,631) (4,345) (10,801) (7,639)
Loss on extinguishment of bonds (10,304)
Interest and investment income 630 1,322 1,443 3,092
Other expense, net 446 (44) (1,346) (154)
Total other expense, net (4,555) (3,067) (21,008) (4,701)
Net (loss) income (176,261) 2,729 (197,612) (19,044)
Net income attributable to redeemable non-controlling interest 680 585 1,026 540
Net (loss) income attributed to Gevo, Inc. (176,941) 2,144 (198,638) (19,584)
Net (loss) income per share basic (0.75) 0.01 (0.84) (0.08)
Net (loss) income per share diluted (0.75) 0.01 (0.84) (0.08)
Weighted-average common shares outstanding basic 237,054,708 232,945,048 237,429,647 232,490,122
Weighted-average common shares outstanding diluted 237,054,708 236,839,117 237,429,647 232,490,122

Condensed Consolidated Balance Sheets (Unaudited)

(Unaudited, in thousands, except share and per share amounts)

Description June 30, 2026 December 31, 2025
Assets
Current assets
Cash and cash equivalents 58,147 81,163
Restricted cash 28,770
Trade accounts receivable, net 11,970 8,394
Inventories 19,304 19,076
Prepaid expenses and other current assets 12,179 6,001
Total current assets 101,600 143,404
Property, plant and equipment, net 238,119 353,577
Restricted cash 7,006
Operating right-of-use assets 2,671 1,964
Finance right-of-use assets 670 430
Intangible assets, net 71,592 95,003
Goodwill 43,558 43,558
Deposits and other assets 32,504 73,987
Total assets 490,714 718,929
Liabilities
Current liabilities
Accounts payable and accrued liabilities 33,391 36,508
Deferred clean fuel production tax credits 3,344 41,115
Operating lease liabilities 817 689
Finance lease liabilities 92 273
Total current liabilities 37,644 78,585
Bonds payable, net 64,247
Loans payable 167,239 100,503
Operating lease liabilities 1,940 1,416
Finance lease liabilities 613 394
Asset retirement obligation 2,326 2,250
Other long-term liabilities 365
Total liabilities 209,762 247,760
Redeemable non-controlling interest 7,789 4,832
Equity
Common stock, $0.01 par value per share; 500,000,000 shares authorized; 247,237,104 and 242,464,470 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively. 2,472 2,425
Additional paid-in capital 1,303,403 1,298,064
Accumulated deficit (1,032,712) (834,152)
Total stockholders' equity 273,163 466,337
Total liabilities and stockholders' equity 490,714 718,929

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Unaudited, in thousands)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Operating Activities
Net loss (197,612) (19,044)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of long-lived assets 135,788
Allowance for credit losses on refundable deposits 39,782
Loss on disposal of property and equipment 210
Loss on extinguishment of bonds 10,304
Stock-based compensation 4,661 4,142
Depreciation and amortization 13,644 12,835
Change in fair value of derivative instruments (2,690) (652)
Production tax credits generated (32,014) (21,494)
Other non-cash expense 2,203 1,274
Changes in operating assets and liabilities, net of effects of acquisition:
Accounts receivable (3,576) (3,634)
Inventories (501) (788)
Prepaid expenses and other current assets, deposits and other assets 475 (9,504)
Accounts payable, accrued expenses and non-current liabilities (7,569) 10,295
Deferred clean fuel production tax credits 7,480
Net cash used in operating activities (29,415) (26,570)
Investing Activities
Acquisitions of property, plant and equipment (21,369) (11,077)
Acquisition of Red Trail Energy, net of cash acquired (198,461)
Issuance of note receivable (250)
Net cash used in investing activities (21,619) (209,538)
Financing Activities
Redemption of bonds (68,155)
Term loan proceeds 70,000 105,000
Payment of debt issuance costs (2,612) (5,480)
Non-controlling interest 5,000
Payment of prepayment penalty on redemption of bonds (6,506)
Proceeds from the exercise of stock options 252 182
Payment of finance lease liabilities (141) (726)
Payments for tax withholdings on employee equity awards (596)
Net cash (used in) provided by financing activities (7,758) 103,976
Net decrease in cash and cash equivalents (58,792) (132,132)
Cash, cash equivalents and restricted cash at beginning of period 116,939 259,033
Cash, cash equivalents and restricted cash at end of period 58,147 126,901

Amounts as printed on the EDGAR/iXBRL face — (Unaudited, in thousands, except share and per share amounts); (Unaudited, in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing